Hero

Celyad announces intiation ot the SHRINK trial

1

Celyad announces intiation ot the SHRINK trial

Celyad publishes additional pre-clinical data in support of THINK trial

2

Celyad publishes additional pre-clinical data in support of THINK trial

Celyad reports promising early results at first dose level of the solid arm of the THINK trial

3

Celyad reports promising early results at first dose level of the solid arm of the THINK trial

FDA grants Fast Track designation for Celyad’s ischemic heart failure therapy, C-Cure®

4

FDA grants Fast Track designation for Celyad’s ischemic heart failure therapy, C-Cure®

Celyad grants to Novartis a non-exclusive license for its allogeneic TCR-deficient CAR-T cells patents

5

Celyad grants to Novartis a non-exclusive license for its allogeneic TCR-deficient CAR-T cells patents

About Celyad

Making the Impossible Possible

Celyad is a clinical-stage biopharmaceutical that is developing next generation CAR-T NK cell-based immunotherapies for cancer treatment.

More info about Celyad

Latest News

Celyad announces initiation of the SHRINK trial

Celyad announces initiation of the SHRINK trial

Celyad publishes additional pre-clinical data in support of THINK trial

Celyad publishes additional pre-clinical data in support of THINK trial

Celyad reports promising early results at first dose level of the solid arm of the THINK trial

Celyad reports promising early results at first dose level of the solid arm of the THINK trial

Discover all news

Carousel

Social Feed

You want to work in a rapidly evolving biotech company? There are currently 11 exciting positions open @Celyad! Have a look at our website: http://bit.ly/2tp0Z48

2 days ago

You want to work in a rapidly evolving biotech company? There are currently 11 exciting positions open @Celyad! Have a look at our website: http://bit.ly/2tp0Z48

Celyad Starts a Third CAR-T Trial, in Metastatic Colorectal Cancer @Labiotech_eu https://t.co/hzWXMB9KEi

2 days ago

Celyad Starts a Third CAR-T Trial, in Metastatic Colorectal Cancer @Labiotech_eu https://t.co/hzWXMB9KEi

Celyad announces initiation of the SHRINK trial https://t.co/h0ofNzlW4q https://t.co/dJNMYwaqaG

6 days ago

Celyad announces initiation of the SHRINK trial https://t.co/h0ofNzlW4q https://t.co/dJNMYwaqaG

Celyad announces the initiation of the SHRINK trial Read the press release: https://lnkd.in/gRnPWTa

6 days ago

Celyad announces the initiation of the SHRINK trial Read the press release: https://lnkd.in/gRnPWTa

Celyad Starts a Third CAR-T Trial, in Metastatic Colorectal Cancer @Labiotech_eu https://t.co/hzWXMB9KEi

2 days ago

Celyad Starts a Third CAR-T Trial, in Metastatic Colorectal Cancer @Labiotech_eu https://t.co/hzWXMB9KEi

Celyad announces initiation of the SHRINK trial https://t.co/h0ofNzlW4q https://t.co/dJNMYwaqaG

6 days ago

Celyad announces initiation of the SHRINK trial https://t.co/h0ofNzlW4q https://t.co/dJNMYwaqaG

Interesting article from Motley Fool on cancer therapy Read the full article: https://t.co/eAQWVRkgoq https://t.co/FEYZy5eV0C

1 week ago

Interesting article from Motley Fool on cancer therapy Read the full article: https://t.co/eAQWVRkgoq https://t.co/FEYZy5eV0C

Celyad's CAR T-cell therapy shows promise in 2 patients with advanced colorectal cancer. Read the full article:… https://t.co/dm6JMnjhqQ

2 weeks ago

Celyad's CAR T-cell therapy shows promise in 2 patients with advanced colorectal cancer. Read the full article:… https://t.co/dm6JMnjhqQ

You want to work in a rapidly evolving biotech company? There are currently 11 exciting positions open @Celyad! Have a look at our website: http://bit.ly/2tp0Z48

2 days ago

You want to work in a rapidly evolving biotech company? There are currently 11 exciting positions open @Celyad! Have a look at our website: http://bit.ly/2tp0Z48

Celyad announces the initiation of the SHRINK trial Read the press release: https://lnkd.in/gRnPWTa

6 days ago

Celyad announces the initiation of the SHRINK trial Read the press release: https://lnkd.in/gRnPWTa

Interesting article from Motley Fool on cancer therapy Read the full article: http://bit.ly/2uDJ8qC

1 week ago

Interesting article from Motley Fool on cancer therapy Read the full article: http://bit.ly/2uDJ8qC

Celyad's CAR T-cell therapy shows promise in 2 patients with advanced colorectal cancer. Read the full article: http://bit.ly/2ts7XCl

2 weeks ago

Celyad's CAR T-cell therapy shows promise in 2 patients with advanced colorectal cancer. Read the full article: http://bit.ly/2ts7XCl